Clarinex Syrup Approved For Use In Children As Young As Six Months
This article was originally published in The Pink Sheet Daily
Schering-Plough agrees to remove promotional claims from the carton for desloratadine syrup as a condition of FDA approval. The company is positioning the formulation as the only prescription non-sedating antihistamine syrup on the market for children down to age six months.
You may also be interested in...
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles
Sepracor's television ads for its sleep aid Lunesta create brand recognition better than other new prescription drug direct-to-consumer ads, according to an analysis performed by IAG Research